In earlier studies, we prepared a docosapeptide, 1, designed with minimum homology as an amphiphilic a-helical model of apolipoprotein A-I (apo A-I) and described its lipid-binding characteristics, surface properties, and enzyme-activating ability. Although the affinity of 1 for egg lecithin unilamellar vesicles was comparable with that for the binding of apo A-I, the affinity of 1 for mixed lecithin/cholesterol (4:1 mol/mol) vesicles was less than that of apo A-I. It Recently, we described the lipid-binding characteristics, surface properties, and enzyme-activating ability of a docosapeptide, 1, designed with minimum homology as an amphiphilic a-helical model ofapolipoprotein A-I (apo A-I) (1, 2). We found that the dissociation constant for the binding of 1 to egg lecithin unilamellar vesicles was approximately the same as that for the binding of apo A-I. In contrast, addition of cholesterol to the lecithin resulted in a lower affinity of 1 for the mixed vesicles compared with that of apo A-I. The mixed vesicles showed, however, the same increased capacity toward both ligands, suggesting that insertion of cholesterol in a phospholipid bilayer creates binding regions for amphiphilic proteins. The exact interaction of proteins with cholesterol thus still remained unspecified. In examining the regions of apo A-I that are thought to form amphiphilic a helices (3), we noted that, in two of these regions-those including Arg-116 and Arg-123-these amino acids were the only hydrophilic residues interrupting an otherwise hydrophobic portion of the helix. In considering our results with model peptide 1, it appeared possible that the 3-hydroxyl group of cholesterol, which is near the outer surface of the vesicle, may have a deleterious interaction with the hydrophobic portion of the amphiphilic helix, which is inserted into the vesicles in the spaces between the phospholipid polar head groups. If this were the case, the preferential interaction of apo A-I with the mixed lecithin/cholesterol vesicles might be due to the presence of the polar arginine residues in the otherwise hydrophobic region of the respective amphiphilic a helices (2, 4). Thus, by incorporating a polar residue into the hydrophobic region of an amphiphilicca helix, we could assess the role of the 3-hydroxyl function of cholesterol in peptide-cholesterol interaction. A very attractive feature of the use of 1 is that, because it is -an idealized model for the predominant secondary structural characteristic of apo A-I-the amphiphilic a helix-and does not follow the amino acid sequence of the native apolipoprotein, specific amino acid replacements can be made on a rational basis and their effects on the chemical and physical properties ofmodels can be tested quantitatively. In this article, we describe the synthesis of a model peptide 2 (Fig. 1) corresponding to the sequence of 1 but containing arginine rather than leucine at position 10 and a systematic study ofthe binding of 2 to single bilayer lecithin vesicles containing cholesterol or cholesterol derivatives.
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EXPERIMENTAL
Materials. Egg yolk lecithin was purchased from Avanti Chemical and cholesterol was from Supelco (Bellefonte, PA). The identity and purity of these compounds were ascertained by thin-layer chromatography (TLC) on silica gel G, using chloroform/methanol/water (70:30:5, vol/vol) for the former and hexane/diethyl ether/acetic acid (65:35:1, vol/vol) for the latter. Cholesterol hemisuccinate was purchased from Steraloids (Pawling, NY), and cholesterol methyl ether was synthesized by the method of Narayanan and Iyer (5) . Both of these cholesterol derivatives were purified by crystallization from methanol, and they were identified and tested for purity by TLC on silica gel G using hexane/diethyl ether/acetic acid (70:30:1, vol/ vol).
The solvents and reagents used for solid-phase peptide synthesis were purified by the methods described previously (6) . Chloromethylated styrene-divinylbenzene copolymer (1% crosslinked) was obtained from Pierce. tert-butoxycarbonyl derivatives of L-alanine, tosyl-L-arginine, E-2-chlorobenzyloxycarbonyl-L-lysine, L-glutamic acid y-benzyl ester, L-leucine, and L-proline were purchased from Bachem Fine Chemicals (Torrance, CA).
The water used for experiments in surface chemistry was redistilled from deionized water in an all-glass apparatus.
Synthesis of Peptide. formamide (7) . The substitution level was 0.3 mmoVg of resin by titration with picric acid (8) . The substituted resin, 1.7 g (0.5 mmol), was placed in the reaction vessel of the synthesizer, and the coupling steps were carried out using the symmetric anhydride method (9) . After completion of the synthesis, the peptide was cleaved from the polymeric support by reaction with anhydrous HF in the presence of anisole at 0C (10) . The mixture of cleaved peptide and resin was washed with 20 ml of CH2Cl2, and then the peptide was extracted with two 50-ml portions of 10% aqueous acetic acid. The extract was lyophilized to obtain 1.24 g of crude peptide.
Purification of the Peptide. The lyophilized product (1.24 g) was suspended in 10 ml of 0.2 M acetic acid, and the mixture was filtered and then loaded onto a Sephadex G-25 Superfine. column (2.2 X 55 cm) equilibrated with 0.2 M acetic acid. Elution was performed using the same solvent at a rate of 15 ml/hr, and 4-ml fractions were collected, monitoring the absorbance at 250 nm. The first small peak (Kv = 0.35) and the ascending part of the second peak (Kv = 0.67) were shown to have essentially the same composition by TLC on cellulose, using 1-butanoVacetic acid/water/pyridine (15:3:12:10, vol/ vol). On the basis of dry weight, 47% of the starting material was recovered in these combined fractions after lyophilization. The lyophilized material was dissolved in 25 ml of0. 02 M phosphate buffer (pH 7.0) and applied to a CM Sephadex C-25 column (2 x 40 cm) equilibrated with the same buffer. After elution with 150 ml of the initial buffer, a linear gradient of NaCl (0-0.3 M/400 ml) in the original buffer was applied to the column. Fractions of 8 (2, 4, 14) . One milliliter of a solution of lecithin, lecithin and cholesterol, or lecithin and cholesterol derivative (4:1, mol/mol) in pure ethanol (10 mg oflecithin/ml) was injected rapidly into 50 ml ofO. 16 M KC1.
After concentration of the solution to a volume of 5 ml, using an Amicon XM 100 membrane, the vesicles were purified using a Sepharose CL-4B column (2.5 x 60 cm), and the eluant was monitored by a differential refractometer (Waters Associates). Fractions (5 ml) were collected, and the phosphorus (15) and cholesterol (16) concentrations were measured. The peak fractions obtained for the unilamellar vesicles were concentrated to 5 ml using an Amicon XM100 membrane. The stability of the vesicles was checked by chromatography on a Sephadex CL-4B column (1.5 
RESULTS
The amino acid composition obtained after acid hydrolysis of the peptide agreed well with the one expected for 2 (Table 1) . Automated Edman degradation of the peptide also gave the predicted sequence ( Table 2) .
The mean residue ellipticity at 222 nm (-4873 ± 70 deg cm2 dmol'-, corresponding to an a helicity of 20%) remained constant throughout the entire concentration range used for the CD measurements in neutral aqueous solution. In the presence of 50% trifluoroethanol, the estimated helicity increased to 60%
([01222 nm = -20,256 deg cm-2dmol'-).
Gel permeation chromatography on Sephadex G-50 showed an apparent Mr of 3000, even at 2.5 mM peptide. This value is values for pure lecithin vesicles. In the cases of the mixed vesicles, the peaks corresponding to cholesterol and to phosphoruscontaining material were coincident, and the molar ratios oflecithin and cholesterol were similar to that in the original ethanolic solution (4:1) in every fraction checked. On storage at 4TC for 1 week, none of the vesicle solutions showed evidence for more than 1% fusion. Binding studies were performed within 3 days ofpreparation of the vesicles. Even after incubation of the vesicles with the peptide at its maximum concentration used in the binding studies for 3 hr at 220C at pH 7.4, the elution profiles for each type ofvesicle, monitored by the refractive index and by cholesterol and phosphorus concentration, did not change. The profiles for the binding of the peptide to each type of vesicle are shown in Fig. 2 . The unilamellar vesicles used in these experiments contained lecithin only, lecithin/cholesterol, lecithin/cholesterol hemisuccinate, or lecithin/cholesterol methyl ether. The molar ratio of lecithin to cholesterol or cholesterol derivatives in the mixed vesicles was 4:1. All ofthe binding curves measured show a saturation, and the data obtained were analyzed as a single Langmuir isothermal absorption (17) . Pf (N PC Pf/Pb) -Kd, where Pf and Pb correspond to the free and bound peptide concentrations, respectively, PC is the concentration of lecithin, N is the upper limit of Pb/PC, and K1 is the dissociation constant. The plots of P vs. PC * Pf/Pb for the data of Fig. 2 are shown in Fig. 3 . In eacht case, a straight line was obtained, indicating that the binding ofthe peptide obeys the law expressed in the equation. The parameters, N and Kd, obtained from Fig.  3 for each binding curve are listed in Table 3 . Addition of 20 mol % of cholesterol to the lecithin vesicles resulted in an increase of 46% in the maximum number of peptide molecules bound to the vesicles and a decrease in Kd by a factor ofone-half. In other words, the peptide had a higher affinity for the cholesterol-containing vesicles than for those which did not contain cholesterol. This is exactly opposite to the case of the amphiphilic synthetic peptide that contained leucine in place of arginine (2) . The effect of added cholesterol methyl ether was an increase in the limiting number of peptide molecules bound similar to that seen in the instance of cholesterol (42%), but the Kd increased for the case of the methyl ether by 70% compared with plain lecithin vesicles. The presence of cholesterol hemisuccinate in the vesicles caused a decrease in the capacity ofthe vesicles for the peptide (44%); but there was a remarkable increase in the binding affinity of the peptide for the vesicles (the value of Kd was l/lo that observed for pure lecithin vesicles).
DISCUSSION
The chemical and physical characteristics of 2 correspond closely to those expected for the replacement of a leucine residue by an arginine residue in the hydrophobic portion of the amphiphilic a helix formed by 1. In particular, unlike the CD spectra of 1, which show a dependence on the concentration of 5 .0 x 10-6 M and 1.9 X 10-6 M, respectively). Thus, the arginine residue at position 10 does have a modest positive effect on the binding of the model peptide to the cholesterol-containing vesicles, as has been predicted. The slight contribution ofthis polar interaction is further supported by the fact that, when the polar alcohol group of cholesterol is etherified, the affinity of2 for the mixed vesicles decreases from Kd = 2.0 X 10-6 M to Kd = 7.4 X 10-6 M. The presence of cholesterol in the vesicles increases their capacity to both 1 and 2. The percentage increase is the same for 1 as for 2. Furthermore, replacement of cholesterol by its methyl ether does not alter the binding capacity of the vesicles. These observations are all consistent with a mode of binding in which the surface bound peptides have the same conformation with and without cholesterol. The decreased capacity of the vesicles toward 2 as compared with that toward 1 also suggests that 2 is bound to the surface in a somewhat less compact conformation than that of the ideal helical peptide 1. Finally, replacement of cholesterol by its hemisuccinate results in a considerable decrease in the capacity of the vesicle to bind 2-from 9.8 x 10-3 mol of peptide/mol of lecithin to 3.7 X 10-3 mol of peptide/mol of lecithin. The hemisuccinate of cholesterol has a highly hydrophilic head group and a length comparable with that of the phospholipids. These features are conducive to a mixed monolayer in which no free space is created between the phospholipid head groups by the introduction of the cholesterol derivative. The increased affinity (Kd = 0.4 X 10-6 M) presumably reflects electrostatic attraction of the positively charged peptide by the carboxylate groups.
The following conclusions emerged from these considerations: (i) Only an energetically modest interaction occurs between the polar group of cholesterol and the appropriately positioned hydrophilic groups of surface-bound peptides and proteins. This interaction is not the major force for binding of proteins to the phospholipid/cholesterol surface, as also noted by Lala et al. (18) , who observed that the biological role of cholesterol can be fulfilled by its methyl ether. (ii) The hydrophobic portion of cholesterol is not a major contributor to the binding of proteins either; Kd values for phospholipid vesicles are of the same order of magnitude as those for mixed cholesterol/phospholipid vesicles.
It is then reasonable to postulate that the major role of cholesterol in the binding of proteins to phospholipid surfaces is the creation offree space between the phospholipid head groups that can accommodate the amphiphilic peptide chains at the interface. Some specific interaction does occur between the cholesterol head group and certain side chains of the peptide, resulting in the formation of weak complexes at the molecular level, but these interactions do not lead to any specific recognition of the mixed surface of the proteins.
